Paralytic ileus responding to somatostatin therapy: first manifestation of a VIPoma

Letters to the editor

To the Editor:

Referring to the article on the use of somatostatin in patients with pancreatic islet cell tumors in a recent issue of your journal (i.e. "Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors"), we wish to report a case of a malignant VIPoma of the pancreas presenting as a paralytic ileus that responded to somatostatin therapy.

About this Letter to the Editor.

See also:

- Official Web Site: The Di Bella Method;

- Somatostatin in oncology, the overlooked evidences - In vitro, review and in vivo publications;

- The Di Bella Method (A Fixed Part - Somatostatin, Octreotide, Sandostatin LAR, analogues and/or derivatives);

- Pancreatic Adenocarcinoma: clinical records on 17 patients treated with Di Bella's Method;

- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer.